Latest Advances in Lung Cancer Research

New blood test using ctDNA methylation biomarkers shows promise for early lung cancer detection, potentially improving treatment outcomes for patients.

New study reveals higher lung cancer incidence in women under 65 than in men, with rates increasing among younger women despite declining smoking trends.

The Monarch Platform robotic tool has revolutionized the way lung cancer is diagnosed and treated at Baptist Health. This cutting-edge technology provides a real-time, high-definition view of the airways, enabling doctors to identify and biopsy suspicious lung nodules with increased accuracy.

Mount Sinai study finds liquid biopsies measuring PD-L1 may better predict lung cancer response to immunotherapy than traditional tumor biopsies.

Lung cancer in never smokers presents unique molecular traits and lower mutation burdens, necessitating distinct treatment strategies and revised screening criteria.

Future of liquid biopsy: Analysis of tumours using biomarkers in blood is beginning to transform cancer diagnosis.

Breast cancer tops lung cancer as most diagnosed cancer. Although breast cancer leads in cases, lung cancer leads in deaths.

Lung cancer stigma negatively impacts the clinical care and outcomes of those diagnosed, resulting in enduring disparities.